» Articles » PMID: 34981667

Increased Mitochondrial Fission Drives the Reprogramming of Fatty Acid Metabolism in Hepatocellular Carcinoma Cells Through Suppression of Sirtuin 1

Overview
Publisher Wiley
Specialty Oncology
Date 2022 Jan 4
PMID 34981667
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mitochondria are dynamic organelles that constantly change their morphology through fission and fusion processes. Recently, abnormally increased mitochondrial fission has been observed in several types of cancer. However, the functional roles of increased mitochondrial fission in lipid metabolism reprogramming in cancer cells remain unclear. This study aimed to explore the role of increased mitochondrial fission in lipid metabolism in hepatocellular carcinoma (HCC) cells.

Methods: Lipid metabolism was determined by evaluating the changes in the expressions of core lipid metabolic enzymes and intracellular lipid content. The rate of fatty acid oxidation was evaluated by [ H]-labelled oleic acid. The mitochondrial morphology in HCC cells was evaluated by fluorescent staining. The expression of protein was determined by real-time PCR, iimmunohistochemistry and Western blotting.

Results: Activation of mitochondrial fission significantly promoted de novo fatty acid synthesis in HCC cells through upregulating the expression of lipogenic genes fatty acid synthase (FASN), acetyl-CoA carboxylase1 (ACC1), and elongation of very long chain fatty acid protein 6 (ELOVL6), while suppressed fatty acid oxidation by downregulating carnitine palmitoyl transferase 1A (CPT1A) and acyl-CoA oxidase 1 (ACOX1). Consistently, suppressed mitochondrial fission exhibited the opposite effects. Moreover, in vitro and in vivo studies revealed that mitochondrial fission-induced lipid metabolism reprogramming significantly promoted the proliferation and metastasis of HCC cells. Mechanistically, mitochondrial fission increased the acetylation level of sterol regulatory element-binding protein 1 (SREBP1) and peroxisome proliferator-activated receptor coactivator 1 alpha (PGC-1α) by suppressing nicotinamide adenine dinucleotide (NAD+)/Sirtuin 1 (SIRT1) signaling. The elevated SREBP1 then upregulated the expression of FASN, ACC1 and ELOVL6 in HCC cells, while PGC-1α/PPARα suppressed the expression of CPT1A and ACOX1.

Conclusions: Increased mitochondrial fission plays a crucial role in the reprogramming of lipid metabolism in HCC cells, which provides strong evidence for the use of this process as a drug target in the treatment of this malignancy.

Citing Articles

Identification of GDP as a small inhibitory molecule in HepG2 cells by non‑targeted metabolomics analysis.

Peng Z, Xu S, Wang H, Huang Y, Liu S, Jiao Z Oncol Lett. 2025; 29(4):178.

PMID: 39990806 PMC: 11843412. DOI: 10.3892/ol.2025.14924.


The Role of Mitochondrial Quality Control in Liver Diseases: Dawn of a Therapeutic Era.

Li J, Liu W, Zhang J, Sun C Int J Biol Sci. 2025; 21(4):1767-1783.

PMID: 39990657 PMC: 11844277. DOI: 10.7150/ijbs.107777.


ACOX1 activates autophagy via the ROS/mTOR pathway to suppress proliferation and migration of colorectal cancer.

Shi B, Chen J, Guo H, Shi X, Tai Q, Chen G Sci Rep. 2025; 15(1):2992.

PMID: 39849090 PMC: 11757735. DOI: 10.1038/s41598-025-87728-8.


CRAT downregulation promotes ovarian cancer progression by facilitating mitochondrial metabolism through decreasing the acetylation of PGC-1α.

Zhang Z, Zhao S, Lv X, Gao Y, Guo Q, Ren Y Cell Death Discov. 2025; 11(1):15.

PMID: 39828731 PMC: 11743791. DOI: 10.1038/s41420-025-02294-2.


DNA methylation of ACADS promotes immunogenic cell death in hepatocellular carcinoma.

Qian Z, Jiang Y, Wang Y, Li Y, Zhang L, Xu X Cell Biosci. 2025; 15(1):3.

PMID: 39800718 PMC: 11727568. DOI: 10.1186/s13578-024-01334-1.


References
1.
Huang Q, Zhan L, Cao H, Li J, Lyu Y, Guo X . Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways. Autophagy. 2016; 12(6):999-1014. PMC: 4922447. DOI: 10.1080/15548627.2016.1166318. View

2.
Takeichi Y, Miyazawa T, Sakamoto S, Hanada Y, Wang L, Gotoh K . Non-alcoholic fatty liver disease in mice with hepatocyte-specific deletion of mitochondrial fission factor. Diabetologia. 2021; 64(9):2092-2107. PMC: 8382662. DOI: 10.1007/s00125-021-05488-2. View

3.
Wen Y, Xiong X, Zaytseva Y, Napier D, Vallee E, Li A . Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer. Cell Death Dis. 2018; 9(3):265. PMC: 5833501. DOI: 10.1038/s41419-018-0330-6. View

4.
Li J, Huang Q, Long X, Zhang J, Huang X, Aa J . CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways. J Hepatol. 2015; 63(6):1378-89. DOI: 10.1016/j.jhep.2015.07.039. View

5.
Tilokani L, Nagashima S, Paupe V, Prudent J . Mitochondrial dynamics: overview of molecular mechanisms. Essays Biochem. 2018; 62(3):341-360. PMC: 6056715. DOI: 10.1042/EBC20170104. View